Pharmaceuticals

US Pharma and Biotech Summit 2024: Improving Healthcare Policy After the 2024 Election

bexib
By bexib 0 Min Read

In an interview with Pharm Exec deputy editor Don Tracy, Robert Zirkelbach, PhRMA’s chief communications officer and head of strategic initiatives, discusses best-case scenarios for health policy ahead of the 2024 presidential election.

You Might Also Like

FDA approves Galderma’s Nemrubio for adults with prurigo nodularis

Study finds SLT for Parkinson’s more effective than that used on the NHS

COA Validation: A Critical Step for Accurate and Reliable Clinical Trial Data

Johnson & Johnson Submits Supplemental New Drug Application to FDA for Spravato as Monotherapy for Adults with Treatment-Resistant Depression

23andMe takes cancer immunotherapy a step closer with genetic database

Share This Article
Previous Article The Tools You Need for a Successful Affiliate Marketing Campaign (2024)
Next Article Identifying and Managing Stripe Rust in Winter Wheat – RealAgriculture
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Top 10 largest fintech acquisitions in Southeast Asia
Fintech
Revolut launches robo-advisor in Singapore
Fintech
This hurricane season, do your customers know the difference between homeowners insurance and flood insurance?
Insurance
Crypto.com launches US institutional exchange
Fintech